APOE and Alzheimer disease: In multiple microglial models, including those derived from AD transgenic mice, human-induced pluripotent stem cell (hiPSC), and mouse N9 microglia transfected with human APOE genes, APOEε4 microglia exhibit reduced process branching, a shortened process length, and enlarged cell bodies, presenting an “activated” morphology [59,60,61].